Abstract

Mucormycosis is an angioinvasive fungal infection, characterized by high morbidity and mortality and is strongly dependent on the patient’s general health condition, initial site of infection, and the time from diagnosis to treatment commencement. It has been reported that the occurrence of mucormycosis has increased rapidly, also among immunocompetent patients. Moreover, the rise in number is expected to continue. Among all clinical manifestations of mucormycosis, the rhino-orbital-cerebral type (ROCM) is the most common. The aim of this article is to increase the awareness of mucoral infections, especially ROCM, and to describe its first symptoms, as proper treatment requires immediate surgical and medical intervention.

References

• 1. Abu El-Naaj I., Leiser Y., Wolff A., Peled M.: The surgical managementof rhinocerebral mucormycosis. J. Craniomaxillofac. Surg.,2013; 41: 291‐–295
  Google Scholar
• 2. Amaro T.A., Yazigi L., Erwenne C.: Depression and quality of lifeduring treatment of ocular bulb removal in individuals with uvealmelanoma. Eur. J. Cancer Care, 2010; 19: 476–481
  Google Scholar
• 3. Ambrosioni J., Bouchuiguir-Wafa K., Garbino J.: Emerging invasivezygomycosis in a tertiary care center: Epidemiology and associatedrisk factors. Int. J. Infect. Dis., 2010; 14: e100‐e103
  Google Scholar
• 4. Arani R., Shareef S.N., Khanam H.M.: Mucormycotic osteomyelitisinvolving the maxilla: A rare case report and review of theliterature. Case Rep. Infect. Dis., 2019; 2019: 8459296
  Google Scholar
• 5. Aras M.H., Kara M.I., Erkiliç S., Ay S.: Mandibular mucormycosisin immunocompromised patients: Report of 2 cases and review ofthe literature. J. Oral Maxillofac. Surg., 2012; 70: 1362–1368
  Google Scholar
• 6. Artis W.M., Fountain J.A., Delcher H.K., Jones H.E.: A mechanismof susceptibility to mucormycosis in diabetic ketoacidosis: Transferrinand iron availability. Diabetes, 1982; 31: 1109–1114
  Google Scholar
• 7. Bailly C., Waring M.J.: Pharmacological effectors of GRP78 chaperonein cancers. Biochem. Pharmacol., 2019; 163: 269–278
  Google Scholar
• 8. Baldin C., Ibrahim A.S.: Molecular mechanisms of mucormycosis– The bitter and the sweet. PLoS Pathog., 2017; 13: e1006408
  Google Scholar
• 9. Baldin C., Soliman S.S.M., Jeon H.H., Alkhazraji S., GebremariamT., Gu Y., Bruno V.M., Cornely O.A., Leather H.L., Sugrue M.W.,Wingard J.R., Stevens D.A., Edwards J.E. Jr., Ibrahim A.S.: PCR-basedapproach targeting mucorales-specific gene family for diagnosis ofmucormycosis. J. Clin. Microbiol., 2018; 56: e00746–18
  Google Scholar
• 10. Bernal-Martínez L., Buitrago M.J., Castelli M.V., Rodriguez-Tudela J.L., Cuenca-Estrella M.: Development of a single tube multiplexreal-time PCR to detect the most clinically relevant Mucormycetesspecies. Clin. Microbiol. Infect., 2013; 19: E1–E7
  Google Scholar
• 11. Bhatnagar A., Agarwal A.: Naso-orbital fistula and socket reconstructionwith radial artery forearm flap following orbital mucormycosis.Natl. J. Maxillofac. Surg., 2016; 7: 197–200
  Google Scholar
• 12. Bitar D., Van Cauteren D., Lanternier F., Dannaoui E., Che D.,Dromer F., Desenclos J.C., Lortholary O.: Increasing incidence ofzygomycosis (mucormycosis), France, 1997–2006. Emerg. Infect.Dis., 2009; 15: 1395–1401
  Google Scholar
• 13. Bongomin F., Gago S., Oladele R.O., Denning D.W.: Global andmulti-national prevalence of fungal diseases-estimate precision.J. Fungi, 2017; 3: 57
  Google Scholar
• 14. Borle R.M.: Textbook of oral and maxillofacial surgery. JaypeeBrothers Medical Publishers, New Delhi 2014
  Google Scholar
• 15. Burnham-Marusich A.R., Hubbard B., Kvam A.J., Gates-HollingsworthM., Green H.R., Soukup E., Limper A.H., Kozel T.R.: Conservationof mannan synthesis in fungi of the Zygomycota andAscomycota reveals a broad diagnostic target. mSphere, 2018;3: e00094–18
  Google Scholar
• 16. Chakrabarti A., Dhaliwal M.: Epidemiology of mucormycosisin India. Curr. Fungal Infect. Rep., 2013; 7: 287–292
  Google Scholar
• 17. Chakrabarti A., Kaur H., Savio J., Rudramurthy S.M., Patel A.,Shastri P., Pamidimukkala U., Karthik R., Bhattacharya S., KindoA.J., Bhattacharya P., Todi S., Gopalakrishan R., Singh P., Pandey A.,Agarwal R.: Epidemiology and clinical outcomes of invasive mouldinfections in Indian intensive care units (FISF study). J. Crit. Care,2019; 51: 64–70
  Google Scholar
• 18. Chakrabarti A., Singh R.: Mucormycosis in India: Unique features.Mycoses. 2014; 57: 85–90
  Google Scholar
• 19. Chikley A., Ben-Ami R., Kontoyiannis D.P.: Mucormycosisof the central nervous system. J. Fungi, 2019; 5: 59
  Google Scholar
• 20. Cornely O.A., Alastruey-Izquierdo A., Arenz D., Chen S.C.A.,Dannaoui E., Hochhegger B., Hoenigl M., Jensen H.E., Lagrou K.,Lewis R.E., Mellinghoff S.C., Mer M., Pana Z.D., Seidel D., SheppardD.C., et al.: Global guideline for the diagnosis and managementof mucormycosis: An initiative of the European Confederation ofMedical Mycology in cooperation with the Mycoses Study GroupEducation and Research Consortium. Lancet Infect. Dis., 2019; 19:e405–e421
  Google Scholar
• 21. Davoudi S., Kumar V.A., Jiang Y., Kupferman M., KontoyiannisD.P.: Invasive mould sinusitis in patients with haematologicalmalignancies: A 10 year single-centre study. J. Antimicrob. Chemother.,2015; 70: 2899–2905
  Google Scholar
• 22. Dökmetaş H.S., Canbay E., Yilmaz S., Elaldi N., Topalkara A.,Oztoprak I., Yildiz E.: Diabetic ketoacidosis and rhino-orbital mucormycosis.Diabetes Res. Clin. Pract., 2002; 57: 139–142
  Google Scholar
• 23. Galletti B., Freni F., Meduri A., Oliverio G.W., Signorino G.A.,Perroni P., Galletti C., Aragona P., Galletti F.: Rhino-orbito-cerebralmucormycosis in diabetic disease. J. Craniofac. Surg., 2020;31: e321–e324
  Google Scholar
• 24. Gebremariam T., Liu M., Luo G., Bruno V., Phan Q.T., WaringA.J., Edwards J.E. Jr., Filler S.G., Yeaman M.R., Ibrahim A.S.:CotH3 mediates fungal invasion of host cells during mucormycosis.J. Clin. Invest., 2014; 124: 237–250
  Google Scholar
• 25. Gillespie M.B., O’Malley B.W. Jr., Francis H.W.: An approach tofulminant invasive fungal rhinosinusitis in the immunocompromisedhost. Arch. Otolaryngol. Head Neck Surg., 1998; 124: 520–526
  Google Scholar
• 26. Gosavi D.K.: Acute necrosis of the maxilla due to mucormycosis.J. Laryngol. Otol., 1978; 92: 365–369
  Google Scholar
• 27. Guinea J., Escribano P., Vena A., Muñoz P., Martínez-JiménezM.D.C., Padilla B., Bouza E.: Increasing incidence of mucormycosisin a large Spanish hospital from 2007 to 2015: Epidemiology andmicrobiological characterization of the isolates. PLoS One, 2017;12: e0179136
  Google Scholar
• 28. Herbrecht R., Sabou M., Ledoux M.P.: Aspects cliniques et radiologiquesdes mucormycoses. Med. Sci., 2013; 29: 19–24
  Google Scholar
• 29. Ibrahim I.M., Abdelmalek D.H., Elfiky A.A.: GRP78: A cell’s responseto stress. Life Sci., 2019; 226: 156–163
  Google Scholar
• 30. Ilharco M., Pereira C.M., Moreira L., Proença A.L., do CarmoFevereiro M., Lampreia F., Oliveira M.L., Rola J.: Rhinoorbital mucormycosisin the immunocompetent: Experience with isavuconazole.ID Cases, 2019; 18: e00591
  Google Scholar
• 31. Inbarajan A., Natarajan S., Thirumalai Thangarajan S.,Seenivasan M., Banu F., Anand Kumar V.: Impact of prosthodontictreatment on the oral health-related quality of life in mucormycosispatient: A case report. Cureus, 2018; 10: e3493
  Google Scholar
• 32. Jeong W., Keighley C., Wolfe R., Lee W.L., Slavin M.A., KongD.C., Chen S.C.: The epidemiology and clinical manifestations ofmucormycosis: A systematic review and meta-analysis of case reports.Clin. Microbiol. Infect., 2019; 25: 26–34
  Google Scholar
• 33. Kasapoglu F., Coskun H., Ozmen O.A., Akalin H., Ener B.: Acuteinvasive fungal rhinosinusitis: Evaluation of 26 patients treatedwith endonasal or open surgical procedures. Otolaryngol. HeadNeck Surg., 2010; 143: 614–620
  Google Scholar
• 34. Koehler P., Mellinghoff S.C., Lagrou K., Alanio A., Arenz D.,Hoenigl M., Koehler F.C., Lass-Flörl C., Meis J.F., Richardson M.,Cornely O.A.: Development and validation of the European QUALity(EQUAL) score for mucormycosis management in haematology.J. Antimicrob. Chemother., 2019; 74: 1704–1712
  Google Scholar
• 35. Kornblith A.B., Zlotolow I.M., Gooen J., Huryn J.M., Lerner T.,Strong E.W., Shah J.P., Spiro R.H., Holland J.C.: Quality of life ofmaxillectomy patients using an obturator prosthesis. Head Neck,1996; 18: 323–334
  Google Scholar
• 36. Li J., Nguyen C.T., Garcia-Diaz J.: Role of new antifungal agentsin the treatment of invasive fungal infections in transplant recipients:Isavuconazole and new posaconazole formulations. J. Fungi,2015; 1: 345‐366
  Google Scholar
• 37. Manfredi M., Polonelli L., Giovati L., Alnuaimi A., McCulloughM.J.: Oral and Maxillofacial Fungal Infections. In: ContemporaryOral Medicine. A Comprehensive Approach to Clinical Practice,eds.: C.S. Farah, R. Balasubramaniam, M.J. McCullough. SpringerInternational Publishing, Cham 2018, 935–981
  Google Scholar
• 38. Mani U.M., Mohamed K., Krishna Kumar A., Inbarajan A.:A modified technique to fabricate a complete hollow obturator forbilateral maxillectomy in a patient with mucormycosis – A technicalcase report. Spec. Care Dentist., 2019; 39: 610‐616
  Google Scholar
• 39. Mathebula S.D.: Mucormycosis. African Vision and Eye Health.2008; 67, 36–41
  Google Scholar
• 40. Mercier T., Reynders M., Beuselinck K., Guldentops E., MaertensJ., Lagrou K.: Serial detection of circulating mucorales DNAin invasive mucormycosis: A retrospective multicenter evaluation.J. Fungi, 2019; 5: 113
  Google Scholar
• 41. Millon L., Scherer E., Rocchi S., Bellanger A.P.: Molecular strategiesto diagnose mucormycosis. J. Fungi, 2019; 5: 24
  Google Scholar
• 42. Navarro-Perea C, Cañas-Zamarra I, Mencía-Gutiérrez E., Revilla-Sánchez E., Lago-Llinás M.D., Pérez-Trigo S., Bengoa-González Á.:Rhino-orbito-cerebral mucormycosis: Two cases with amaurosis aspresentation, medical surgical management and follow-up. CaseRep. Ophthalmol Med., 2019; 2019: 4215989
  Google Scholar
• 43. Ogawa T., Takezawa K., Tojima I., Shibayama M., Kouzaki H.,Ishida M., Okabe H., Shimizu T.: Successful treatment of rhinoorbitalmucormycosis by a new combination therapy with liposomalamphotericin B and micafungin. Auris Nasus Larynx., 2012;39: 224‐228
  Google Scholar
• 44. Oh W.S., Roumanas E.: Dental implant-assisted prosthetic rehabilitationof a patient with a bilateral maxillectomy defect secondaryto mucormycosis. J. Prosthet. Dent., 2006; 96: 88–95
  Google Scholar
• 45. Paltauf A.: Mycosis mucorina. Archiv F. Pathol. Anat., 1885;102: 543–564
  Google Scholar
• 46. Prakash H., Chakrabarti A.: Global epidemiology of mucormycosis.J. Fungi, 2019; 5: 26
  Google Scholar
• 47. Prakash H., Ghosh A.K., Rudramurthy S.M., Singh P., Xess I.,Savio.J, Pamidimukkala U., Jillwin J., Varma S., Das A., Panda N.K.,Singh S., Bal A., Chakrabarti A.: A prospective multicenter study onmucormycosis in India: Epidemiology, diagnosis, and treatment.Med. Mycol., 2019; 57: 395–402
  Google Scholar
• 48. Ramadorai A., Ravi P., Narayanan V.: Rhinocerebral mucormycosis:A prospective analysis of an effective treatment protocol.Ann. Maxillofac. Surg., 2019; 9: 192–196
  Google Scholar
• 49. Saegeman V., Maertens J., Meersseman W., Spriet I., VerbekenE., Lagrou K.: Increasing incidence of mucormycosis in UniversityHospital, Belgium. Emerg. Infect. Dis., 2010; 16: 1456‐1458
  Google Scholar
• 50. Schwarz P., Guedouar H., Laouiti F., Grenouillet F., DannaouiE.: Identification of mucorales by matrix-assisted laser desorptionionization time-of-flight mass spectrometry. J. Fungi, 2019; 5: 56
  Google Scholar
• 51. Serris A., Danion F., Lanternier F.: Disease entities in mucormycosis.J. Fungi, 2019; 5: 23
  Google Scholar
• 52. Spellberg B., Edwards J. Jr., Ibrahim A.: Novel perspectives onmucormycosis: Pathophysiology, presentation, and management.Clin. Microbiol. Rev., 2005; 18: 556–569
  Google Scholar
• 53. Trifilio S., Singhal S., Williams S., Frankfurt O., Gordon L., EvensA., Winter J., Tallman M., Pi J., Mehta J.: Breakthrough fungal infectionsafter allogeneic hematopoietic stem cell transplantation inpatients on prophylactic voriconazole. Bone Marrow Transplant.,2007; 40: 451–456
  Google Scholar
• 54. Turner J.H., Soudry E., Nayak J.V., Hwang P.H.: Survival outcomesin acute invasive fungal sinusitis: A systematic review andquantitative synthesis of published evidence. Laryngoscope, 2013;123: 1112–1118
  Google Scholar
• 55. Walsh T.J., Hospenthal D.R., Petraitis V., Kontoyiannis D.P.:Necrotizing mucormycosis of wounds following combat injuries,natural disasters, burns, and other trauma. J. Fungi, 2019; 5: 57
  Google Scholar
• 56. Walther G., Wagner L., Kurzai O.: Updates on the taxonomyof mucorales with an emphasis on clinically important taxa. J.Fungi, 2019; 5: 106
  Google Scholar
• 57. Zuniga M.G., Turner J.H.: Treatment outcomes in acute invasivefungal rhinosinusitis. Curr. Opin. Otolaryngol. Head NeckSurg., 2014; 22: 242–248
  Google Scholar

Full text